VIMIAN Intrinsic Valuation and Fundamental Analysis - Vimian Group AB - Alpha Spread
V

Vimian Group AB
STO:VIMIAN

Watchlist Manager
Vimian Group AB
STO:VIMIAN
Watchlist
Price: 43.7 SEK 1.63%
Market Cap: 22.6B SEK
Have any thoughts about
Vimian Group AB?
Write Note

Intrinsic Value

The intrinsic value of one VIMIAN stock under the Base Case scenario is 46.2 SEK. Compared to the current market price of 43.7 SEK, Vimian Group AB is Undervalued by 5%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

VIMIAN Intrinsic Value
46.2 SEK
Undervaluation 5%
Intrinsic Value
Price
V
Worst Case
Base Case
Best Case

Valuation Backtest
Vimian Group AB

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling VIMIAN based on its intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?
How do you feel about VIMIAN?
Bearish
Neutral
Bullish

Fundamental Analysis

Summary

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Wall St Estimates
Price Target
Loading
Revenue Forecast
Operating Income Forecast
Earnings Forecast
No Indicators Selected
Select Indicators
Investor Returns
Shareholder Yield
Dividend Safety
Dividend Yield
Dividend Payout Ratio
Buyback Yield
Debt Paydown Yield
No Indicators Selected
Select Indicators
Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

AI Assistant
AI Assistant
Ask me anything about Vimian Group AB

Provide an overview of the primary business activities
of Vimian Group AB.

What unique competitive advantages
does Vimian Group AB hold over its rivals?

What risks and challenges
does Vimian Group AB face in the near future?

Summarize the latest earnings call
of Vimian Group AB.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Vimian Group AB.

Provide P/S
for Vimian Group AB.

Provide P/E
for Vimian Group AB.

Provide P/OCF
for Vimian Group AB.

Provide P/FCFE
for Vimian Group AB.

Provide P/B
for Vimian Group AB.

Provide EV/S
for Vimian Group AB.

Provide EV/GP
for Vimian Group AB.

Provide EV/EBITDA
for Vimian Group AB.

Provide EV/EBIT
for Vimian Group AB.

Provide EV/OCF
for Vimian Group AB.

Provide EV/FCFF
for Vimian Group AB.

Provide EV/IC
for Vimian Group AB.

Show me price targets
for Vimian Group AB made by professional analysts.

What are the Revenue projections
for Vimian Group AB?

How accurate were the past Revenue estimates
for Vimian Group AB?

What are the Net Income projections
for Vimian Group AB?

How accurate were the past Net Income estimates
for Vimian Group AB?

What are the EPS projections
for Vimian Group AB?

How accurate were the past EPS estimates
for Vimian Group AB?

What are the EBIT projections
for Vimian Group AB?

How accurate were the past EBIT estimates
for Vimian Group AB?

Compare the revenue forecasts
for Vimian Group AB with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Vimian Group AB and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Vimian Group AB against its competitors.

Analyze the profit margins
(gross, operating, and net) of Vimian Group AB compared to its peers.

Compare the P/E ratios
of Vimian Group AB against its peers.

Discuss the investment returns and shareholder value creation
comparing Vimian Group AB with its peers.

Analyze the financial leverage
of Vimian Group AB compared to its main competitors.

Show all profitability ratios
for Vimian Group AB.

Provide ROE
for Vimian Group AB.

Provide ROA
for Vimian Group AB.

Provide ROIC
for Vimian Group AB.

Provide ROCE
for Vimian Group AB.

Provide Gross Margin
for Vimian Group AB.

Provide Operating Margin
for Vimian Group AB.

Provide Net Margin
for Vimian Group AB.

Provide FCF Margin
for Vimian Group AB.

Show all solvency ratios
for Vimian Group AB.

Provide D/E Ratio
for Vimian Group AB.

Provide D/A Ratio
for Vimian Group AB.

Provide Interest Coverage Ratio
for Vimian Group AB.

Provide Altman Z-Score Ratio
for Vimian Group AB.

Provide Quick Ratio
for Vimian Group AB.

Provide Current Ratio
for Vimian Group AB.

Provide Cash Ratio
for Vimian Group AB.

What is the historical Revenue growth
over the last 5 years for Vimian Group AB?

What is the historical Net Income growth
over the last 5 years for Vimian Group AB?

What is the current Free Cash Flow
of Vimian Group AB?

Discuss the annual earnings per share (EPS)
trend over the past five years for Vimian Group AB.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Vimian Group AB

Current Assets 190.4m
Cash & Short-Term Investments 41.2m
Receivables 73.2m
Other Current Assets 75.9m
Non-Current Assets 806.2m
Long-Term Investments 49.1m
PP&E 36.5m
Intangibles 718.5m
Other Non-Current Assets 2.1m
Current Liabilities 94.8m
Accounts Payable 25.7m
Accrued Liabilities 15.8m
Other Current Liabilities 53.3m
Non-Current Liabilities 225.5m
Long-Term Debt 178.6m
Other Non-Current Liabilities 46.9m
Efficiency

Earnings Waterfall
Vimian Group AB

Revenue
344.6m EUR
Cost of Revenue
-182m EUR
Gross Profit
162.6m EUR
Operating Expenses
-123.4m EUR
Operating Income
39.2m EUR
Other Expenses
-29.4m EUR
Net Income
9.8m EUR

Free Cash Flow Analysis
Vimian Group AB

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

Vimian Group reported a strong second quarter with 11% organic growth, driven by its three main segments. Specialty Pharma saw 13% growth, while MedTech posted 10%, despite a slowdown in the U.S. surgical market. Veterinary Services grew by 18%, recruiting 400 new member clinics. Adjusted EBITA margin improved from 25% to 27.2%. The company's leverage is reduced to 1.4x, enabling further acquisitions. Vimian remains optimistic about achieving high single-digit organic growth for the full year, except for diagnostics, which faced a 9% revenue decline.

What is Earnings Call?
Fundamental Scores

VIMIAN Profitability Score
Profitability Due Diligence

Vimian Group AB's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Years Revenue Growth
Positive Revenue Growth Forecast
Positive Operating Income
50/100
Profitability
Score

Vimian Group AB's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

VIMIAN Solvency Score
Solvency Due Diligence

Vimian Group AB's solvency score is 57/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
57/100
Solvency
Score

Vimian Group AB's solvency score is 57/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

VIMIAN Price Targets Summary
Vimian Group AB

Wall Street analysts forecast VIMIAN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VIMIAN is 44.17 SEK with a low forecast of 28.28 SEK and a high forecast of 61.95 SEK.

Lowest
Price Target
28.28 SEK
35% Downside
Average
Price Target
44.17 SEK
1% Upside
Highest
Price Target
61.95 SEK
42% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for VIMIAN?

Click here to dive deeper.

Shareholder Yield

Current shareholder yield for VIMIAN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Want to learn more about VIMIAN dividends, buybacks, and debt paydown yield?

Click here to dive deeper.

VIMIAN Price
Vimian Group AB

1M 1M
+7%
6M 6M
+47%
1Y 1Y
+100%
3Y 3Y
-52%
5Y 5Y
-44%
10Y 10Y
-44%
Annual Price Range
43.7
52w Low
20.0822
52w High
45.4
Price Metrics
Average Annual Return -32.89%
Standard Deviation of Annual Returns 45.82%
Max Drawdown -83%
Shares Statistics
Market Capitalization 22.5B SEK
Shares Outstanding 517 032 000
Percentage of Shares Shorted
N/A

Competitive Landscape

Profile

Vimian Group AB

Country

Sweden

Industry

Health Care

Market Cap

22.5B SEK

Dividend Yield

0%

Description

Vimian Group AB operates as an animal health company. The company is headquartered in Stockholm, Stockholm and currently employs 1,068 full-time employees. The company went IPO on 2021-06-18. The firm is a parent company of the group of companies operating with a purpose of improving animal health through science and technology. The Group delivers solutions to veterinary professionals, labs and pet parents around the world. The purpose of Vimian Group is to unite companies in selected niches of animal health and help them grow faster. The firm invests in innovation and new technologies to advance veterinary medicine. The Group covers four essential and rapidly evolving areas within animal health: Specialty Pharma, Diagnostics, Veterinary Services and MedTech. Vimian provides individual businesses with access to its networks, advisory services, infrastructure and capital.

Contact

STOCKHOLM
Stockholm
Riddargatan 19
+46727248045
vimian.com

IPO

2021-06-18

Employees

1 068

Officers

See Also

Discover More
What is the Intrinsic Value of one VIMIAN stock?

The intrinsic value of one VIMIAN stock under the Base Case scenario is 46.2 SEK.

Is VIMIAN stock undervalued or overvalued?

Compared to the current market price of 43.7 SEK, Vimian Group AB is Undervalued by 5%.

Back to Top